Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02576860 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3 study, sponsored by Maruho Co..
- Completed
- Registry status
- Phase 3
- Development phase
- 263
- Enrollment target
NCT02576860: Completed Phase 3 study, sponsored by Maruho Co..
NCT02576860 is a Phase 3 study that has completed, run by Maruho Co.. The registered enrollment target is 263 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02576860, a Phase 3 study, has completed, sponsored by Maruho Co..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 263 participants
- Enrollment target
Study Summary
This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.
Primary Outcome
Absolute change in inflammatory lesion count from baseline to Week 12.
Interventions
- DRUG Vehicle
- DRUG CLS001 (Omiganan)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-09-05 |
| Phase | Phase 3 |
What the finished NCT02576860 record still lists
NCT02576860 is an interventional study that assigns participants to a tested intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT02576860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02576860 about?
NCT02576860 is a clinical study titled "Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle". This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.
What is the current status of trial NCT02576860?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 263 participants. The study started on 2015-10. Estimated completion is 2017-09-05.
What interventions are being tested in trial NCT02576860?
The interventions under investigation include: Vehicle (DRUG), CLS001 (Omiganan) (DRUG).
Who is sponsoring clinical trial NCT02576860?
This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02576860's enrollment target sits among peer trials
263 1228th of 2000 higher than 773 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia